These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6485659)

  • 41. Causal relationship between immunological responses and adverse reactions following vaccination.
    Nakayama T
    Vaccine; 2019 Jan; 37(2):366-371. PubMed ID: 30503656
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Indices of humoral antimeasles postvaccinal immunity].
    Tikhonova NT; Prokudina IuA; Khrometskaia TM; Potemkina EE
    Vopr Virusol; 1975; (3):287-92. PubMed ID: 1162947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Measles immunization and its problems].
    Kökkaya A
    Mikrobiyol Bul; 1982 Jan; 16(1):66-70. PubMed ID: 7144618
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Stimulation of homo- and heterologic T-cell immunological memory in volunteers inoculated with live influenza A (H5N2) reassortant vaccine].
    Naĭkhin AN; Chirkova TV; Petukhova GD; Koren'kov DA; Donina SA; Rudenko LG
    Vopr Virusol; 2012; 57(1):38-42. PubMed ID: 22624472
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) pilot study: a cluster randomized trial.
    Kwong JC; Pereira JA; Quach S; Pellizzari R; Dusome E; Russell ML; Hamid JS; Feinberg Y; Winter AL; Gubbay JB; Sirtonski B; Moher D; Sider D; Finkelstein M; Loeb M;
    Vaccine; 2015 Jan; 33(4):535-41. PubMed ID: 25488331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Live attenuated influenza vaccine for children.
    Drug Ther Bull; 2017 Oct; 55(10):114-117. PubMed ID: 29021248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Vaccinal prevention of influenza in children].
    Zykov MP; Vasil'eva RI
    Tr Inst Im Pastera; 1982; 58():30-8. PubMed ID: 6764981
    [No Abstract]   [Full Text] [Related]  

  • 48. Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans.
    Etchart N; Hennino A; Friede M; Dahel K; Dupouy M; Goujon-Henry C; Nicolas JF; Kaiserlian D
    Vaccine; 2007 Sep; 25(39-40):6891-9. PubMed ID: 17764789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experimental vaccines against measles in a world of changing epidemiology.
    Pütz MM; Bouche FB; de Swart RL; Muller CP
    Int J Parasitol; 2003 May; 33(5-6):525-45. PubMed ID: 12782053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigation and appplication of the USSR AMS live measles vaccine from the ESC strain for mass vaccination against measles.
    Chumakov MP; Voroshilova MK; Grachev VP; Sinyak KM; Boiko VM; Seibil VB; Rodin VI; Piven GG
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(1):1-18. PubMed ID: 4985647
    [No Abstract]   [Full Text] [Related]  

  • 51. Inactivated measles virus vaccine. Subsequent challenge with attenuated live virus vaccine.
    KARELITZ S; BERLINER BC; ORANGE M; PENBHARKKUL S; RAMOS A; MUENBOON P
    JAMA; 1963 Jun; 184():673-9. PubMed ID: 13962482
    [No Abstract]   [Full Text] [Related]  

  • 52. Effectiveness and safety of influenza vaccination in children: European perspective.
    Heikkinen T; Heinonen S
    Vaccine; 2011 Oct; 29(43):7529-34. PubMed ID: 21820481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011.
    Girard MP; Katz JM; Pervikov Y; Hombach J; Tam JS
    Vaccine; 2011 Oct; 29(44):7579-86. PubMed ID: 21856358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Studies of the live AMN USSR measles vaccine from the ESC strain and its use and problems of mass vaccinations against measles].
    Czumakow MP; Woroszylowa MK; Graczew WP; Sinjak KM; Bojko WM; Sejbil WB; Rodin WI; Piwień GG
    Przegl Epidemiol; 1970; 24(2):205-11. PubMed ID: 5431794
    [No Abstract]   [Full Text] [Related]  

  • 55. Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination.
    Mohn KGI; Zhou F; Brokstad KA; Sridhar S; Cox RJ
    J Infect Dis; 2017 May; 215(10):1527-1535. PubMed ID: 28368530
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effectiveness of the 2012/13 trivalent live and inactivated influenza vaccines in children and adolescents in Saxony-Anhalt, Germany: a test-negative case-control study.
    Helmeke C; Gräfe L; Irmscher HM; Gottschalk C; Karagiannis I; Oppermann H
    PLoS One; 2015; 10(4):e0122910. PubMed ID: 25885063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Efficacy of influenza prophylaxis with inactivated vaccines].
    Slobodeniuk AV; Vaserin IuI; Kramarevskiĭ VA; Filimonov VB; Glotov IuP
    Voen Med Zh; 1983 Feb; (2):41-2. PubMed ID: 6845664
    [No Abstract]   [Full Text] [Related]  

  • 58. [Immunological reactivity of children vaccinated with a live measles vaccine].
    Bolotovskiĭ VM; Titova NS; Zakharova TR; Vorotyntseva NV; Mushkova EM
    Vopr Virusol; 1983; 28(5):588-90. PubMed ID: 6659474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measles vaccine: a 27-year follow-up.
    Ramsay ME; Moffatt D; O'Connor M
    Epidemiol Infect; 1994 Apr; 112(2):409-12. PubMed ID: 8150015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is Dr von Magnus to blame for the withdrawal of live attenuated influenza vaccine?
    Griffiths PD
    Rev Med Virol; 2018 Jan; 28(1):. PubMed ID: 29143392
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.